Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic liver tumors.

M D McCarter1, Y Fong

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Seminars in Surgical Oncology
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

The effect of preoperative nutritional status on postoperative complications and overall survival in patients undergoing pelvic exenteration: A multi-disciplinary, multi-institutional cohort study.

American journal of surgery·2019
Same author

Propensity score-matched comparison of oncological outcomes between laparoscopic and open distal pancreatic resection.

The British journal of surgery·2018
Same author

Influence of tumor size on outcomes following pelvic exenteration.

Gynecologic oncology·2017
Same author

Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.

Oncogene·2017
Same author

A practical guide to development of a successful robotic abdominal surgery program: The path to implementation.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2017

Liver resection offers a potential cure for metastatic cancer with low mortality. This review covers prognostic factors, imaging, and adjuvant therapies for liver metastases, including neuroendocrine and renal cell tumors.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Oncology

Background:

  • The liver is a frequent site for metastasis from various primary cancers.
  • Liver resection is a potentially curative treatment for select patients with liver metastases.
  • Survival rates after resection for colorectal metastases are established, but data for other tumor types are less clear.

Purpose of the Study:

  • To review prognostic factors guiding patient selection for liver resection of metastatic disease.
  • To provide recommendations for imaging and follow-up protocols.
  • To discuss adjuvant therapies and ablative techniques for unresectable liver metastases.

Main Methods:

  • Review of existing literature on liver resection for metastatic disease.
  • Analysis of prognostic factors influencing outcomes.

Related Experiment Videos

  • Evaluation of imaging modalities and follow-up strategies.
  • Discussion of adjuvant and ablative treatment options.

    • Main Results:

    • Liver resection for colorectal metastases yields 5-year survival of 25-37%.
    • Resection can offer durable palliation or cure for selected neuroendocrine and renal cell metastases.
    • Prognostic factors are crucial for selecting appropriate candidates for surgery.

    Conclusions:

    • Liver resection is a viable option for select patients with metastatic cancer to the liver.
    • Careful patient selection based on prognostic factors is essential for successful outcomes.
    • Adjuvant therapies and ablative methods may complement surgical treatment.